Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric cancer

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 9, 2014, Pages 5902-5908

  Zhang, Xiao Mei ^a   Zhou, Chuanwen ^b   Gu, Huan ^a   Yan, Lu ^a   Zhang, Gui Ying ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cyclin D1; Gastric cancer; Raf kinase inhibitor protein (RKIP); STAT3

Indexed keywords

CCND1 PROTEIN, HUMAN; CYCLIN D1; MESSENGER RNA; PEBP1 PROTEIN, HUMAN; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN; TUMOR MARKER;

ADENOMATOUS POLYP; CARCINOMA; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; METABOLISM; METAPLASIA; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SECONDARY; STOMACH TUMOR; TUMOR CELL LINE; TUMOR INVASION;

ADENOMATOUS POLYPS; BIOMARKERS, TUMOR; CARCINOMA; CELL LINE, TUMOR; CYCLIN D1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; METAPLASIA; MIDDLE AGED; NEOPLASM INVASIVENESS; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; STOMACH NEOPLASMS;

EID: 84911499006     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Herszényi L, Tulassay Z. Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci 2010; 14: 249-258.
2. Keller ET, Fu Z, Brennan M. The role of Raf kinase inhibitor protein (RKIP) in health and disease. Biochem Pharmacol 2004; 68: 1049-1053.
3. Zeng L, Imamoto A, Rosner MR. Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target. Expert Opin Ther Targets 2008; 12: 1275-1287.
4. Granovsky AE, Rosner MR. Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor. Cell Res 2008; 18: 452-457.
5. Fu Z, Kitagawa Y, Shen R, Shah R, Mehra R, Rhodes D, Keller PJ, Mizokami A, Dunn R, Chinnaiyan AM, Yao Z, Keller ET. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate 2006; 66: 248-256.
6. Hagan S, Al-Mulla F, Mallon E, Oien K, Ferrier R, Gusterson B, García JJ, Kolch W. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res 2005; 11: 7392-7397.
7. Schuierer MM, Bataille F, Hagan S, Kolch W, Bosserhoff AK. Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Res 2004; 64: 5186-5192.
8. Mc Henry KT, Montesano R, Zhu S, Beshir AB, Tang HH, Yeung KC, Fenteany G. Raf kinase inhibitor protein positively regulates cell-substratum adhesion while negatively regulating cell-cell adhesion. J Cell Biochem 2008; 103: 972-985.
9. Eves EM, Shapiro P, Naik K, Klein UR, Trakul N, Rosner MR. Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint. Mol Cell 2006; 23: 561-754.
10. Eves EM, Rosner MR. MAP kinase regulation of the mitotic spindle checkpoint. Methods Mol Biol 2010; 661: 497-505.
11. Alao JP. The regulation of cyclin D1 degradaion: roles in cancer development and the potential for therapeutic invention. Mol Cancer 2007; 6: 24
12. Johnston PA, Grandis JR. STAT3 signaling: anticancer strategies and challenges. Mol Interv 2011; 11: 18-26.
13. Chatterjee D, Sabo E, Tavares R, Resnick MB. Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome. Clin Cancer Res 2008; 14: 2994-3001.
14. al-Mulla F, Bitar MS, Taqi Z, Rath O, Kolch W. RAF kinase inhibitory protein (RKIP) modulates cell cycle kinetics and motility. Mol Biosyst 2011; 7: 928-941.
15. Zhang XM, Gu H, Yan L, Zhang GY. RKIP inhibits the malignant phenotypes of gastric cancer cells. Neoplasma 2013; 60: 196-202.
16. Wang J, Yang YH, Wang AQ, Yao B, Xie G, Feng G, Zhang Y, Cheng ZS, Hui L, Dai TZ, Du XB, Wang D. Immunohistochemical detection of the Raf kinase inhibitor protein in nonneoplastic gastric tissue and gastric cancer tissue. Med Oncol 2010; 27: 219-223.
17. Jia B, Liu H, Kong Q, Li B. RKIP expression associated with gastric cancer cell invasion and metastasis. Tumour Biol 2012; 33: 919-925.
18. Fujimori Y, Inokuchi M, Takagi Y, Kato K, Kojima K, Sugihara K. Prognostic value of RKIP and p-ERK in gastric cancer. J Exp Clin Cancer Res 2012; 31: 30.
19. Hsu YF, Lee TS, Lin SY, Hsu SP, Juan S. Involvement of Ras/Raf-1/ERK actions in the magnolol-induced upregulation of p21 and cell-cycle arrest in colon cancer cells. Mol Carcinog 2007; 46: 275-83.
20. Han JC, Zhang KL, Chen XY, Jiang HF, Kong QY, Sun Y, Wu ML, Huang L, Li H, Liu J. Expression of seven gastric cancer-associated genes and its relevance for Wnt, NF-kappaB and Stat3 signaling. APMIS 2007; 115: 1331-1343.
21. Wu LJ, Li HX, Luo XT, Lu RZ, Ma YF, Wang R, Zhang J, Yang DQ, Yu H, Liu J. STAT3 activation in tumor cell-free lymph nodes predicts a poor prognosis for gastric cancer. Int J Clin Exp Pathol 2014; 7: 1140-6.
22. Leslie K, Lang C, Devgan G, Azare J, Berishaj M, Gerald W, Kim YB, Paz K, Darnell JE, Albanese C, Sakamaki T, Pestell R, Bromberg J. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3. Cancer Res 2006; 66: 2544-2552.